174 related articles for article (PubMed ID: 23988813)
1. Second transurethral resection after Ta high-grade bladder tumor: a 4.5-year period at a single university center.
Lazica DA; Roth S; Brandt AS; Böttcher S; Mathers MJ; Ubrig B
Urol Int; 2014; 92(2):131-5. PubMed ID: 23988813
[TBL] [Abstract][Full Text] [Related]
2. [T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases].
Lazica DA; Böttcher S; Degener S; von Rundstedt FC; Brandt AS; Roth S; Störkel S; Mathers MJ
Aktuelle Urol; 2013 Mar; 44(2):124-8. PubMed ID: 23580383
[TBL] [Abstract][Full Text] [Related]
3. [Impact of operator experience on TURB of high-grade non-muscle-invasive bladder cancer--analysis of 254 second resections at a university teaching hospital].
Lazica DA; Degener S; Böttcher S; Brandt AS; Störkel S; Roth S
Aktuelle Urol; 2013 May; 44(3):196-200. PubMed ID: 23712276
[TBL] [Abstract][Full Text] [Related]
4. [Should we propose a systematic second transurethral resection of the bladder for all high-risk non-muscle invasive bladder cancers?].
Lipsker A; Hammoudi Y; Parier B; Drai J; Bahi R; Bessede T; Patard JJ; Pignot G
Prog Urol; 2014 Sep; 24(10):640-5. PubMed ID: 25214293
[TBL] [Abstract][Full Text] [Related]
5. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
6. Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology.
Neuzillet Y; Methorst C; Schneider M; Lebret T; Rouanne M; Radulescu C; Molinie V; Dreyfus JF; Pelcat V; Botto H
Urol Oncol; 2014 Nov; 32(8):1135-40. PubMed ID: 25023786
[TBL] [Abstract][Full Text] [Related]
7. [Repeat transurethral resection for non-muscle invasive bladder cancer].
Shen YJ; Ye DW; Yao XD; Zhang SL; Dai B; Zhu YP; Zhang HL; Zhu Y; Shi GH; Ma CG
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):725-7. PubMed ID: 19615201
[TBL] [Abstract][Full Text] [Related]
8. Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?
Süer E; Özcan C; Baltacı S; Gülpınar Ö; Burgu B; Haliloğlu A; Bedük Y
Urol Int; 2013; 91(2):182-6. PubMed ID: 23751593
[TBL] [Abstract][Full Text] [Related]
9. The value of a second transurethral resection in evaluating patients with bladder tumors.
Herr HW
J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
[TBL] [Abstract][Full Text] [Related]
10. A prospective evaluation of second transurethral resection in non-muscle invasive bladder tumors.
Aydin M; Tandogdu Z; Kurtulus FO; Avci E; Fazlioglu A; Cek M
J BUON; 2010; 15(3):514-7. PubMed ID: 20941820
[TBL] [Abstract][Full Text] [Related]
11. [Interest of reTURB for pTa high grade bladder urothelial carcinoma].
Branchu B; Léon P; Jeglinschi SC; Durlach A; Trigui S; Birembaut P; Larré S
Prog Urol; 2020 Jan; 30(1):19-25. PubMed ID: 31866142
[TBL] [Abstract][Full Text] [Related]
12. Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors.
Herkommer K; Hofer C; Gschwend JE; Kron M; Treiber U
J Urol; 2012 May; 187(5):1566-70. PubMed ID: 22425072
[TBL] [Abstract][Full Text] [Related]
13. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.
Kamiya N; Suzuki H; Suyama T; Kobayashi M; Fukasawa S; Sekita N; Mikami K; Nihei N; Naya Y; Ichikawa T
Int J Clin Oncol; 2017 Apr; 22(2):353-358. PubMed ID: 27744487
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
[TBL] [Abstract][Full Text] [Related]
16. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?
Divrik T; Yildirim U; Eroğlu AS; Zorlu F; Ozen H
J Urol; 2006 Apr; 175(4):1258-61. PubMed ID: 16515974
[TBL] [Abstract][Full Text] [Related]
17. The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer.
Guevara A; Salomon L; Allory Y; Ploussard G; de la Taille A; Paul A; Yiou R; Hoznek A; Dahan M; Abbou CC; Vordos D
J Urol; 2010 Jun; 183(6):2161-4. PubMed ID: 20399454
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
19. Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists.
Zurkirchen MA; Sulser T; Gaspert A; Hauri D
Urol Int; 2004; 72(2):99-102. PubMed ID: 14963348
[TBL] [Abstract][Full Text] [Related]
20. Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor.
Kim W; Song C; Park S; Kim J; Park J; Kim SC; Cho YM; Hong B; Ahn H
J Endourol; 2012 Aug; 26(8):1059-64. PubMed ID: 22390720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
